It has the effect of directly stimulating vascular α1 receptors and causing vasoconstriction, thereby alleviating congestion and edema caused by inflammation.

Timolol maleate is a non-selective beta-adrenergic receptor blocker with no obvious endogenous sympathomimetic activity and local anesthetic effect, and no direct inhibitory effect on the myocardium. The exact mechanism of its lowering intraocular pressure is still unclear, and intraocular pressure recording and aqueous humor fluorescence studies suggest that the intraocular pressure-lowering effect of this product is related to reducing aqueous humor production.

This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on dermatophytes, Candida, etc., and also has a certain effect on some Gram-positive cocci.

This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on dermatophytes, Candida, etc., and also has a certain effect on some Gram-positive cocci.

This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on dermatophytes, Candida, etc., and also has a certain effect on some Gram-positive cocci.

This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on dermatophytes, Candida, etc., and also has a certain effect on some Gram-positive cocci.

This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on dermatophytes, Candida, etc., and also has a certain effect on some Gram-positive cocci.

This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on dermatophytes, Candida, etc., and also has a certain effect on some Gram-positive cocci.

This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on dermatophytes, Candida, etc., and also has a certain effect on some Gram-positive cocci.

This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on dermatophytes, Candida, etc., and also has a certain effect on some Gram-positive cocci.

This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on dermatophytes, Candida, etc., and also has a certain effect on some Gram-positive cocci.

This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on dermatophytes, Candida, etc., and also has a certain effect on some Gram-positive cocci.

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial effect on most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good resistance to Chlamydia trachomatis, Mycoplasma and Legionella.

It has special effects on Staphylococci (such as Staphylococcus aureus, Staphylococcus epidermidis and penicillin-resistant strains), Streptococci (such as group A hemolytic streptococci, non-hemolytic streptococci and Streptococcus pneumoniae), Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis (indole-negative) and indole-positive Proteus, Haemophilus influenzae and Haemophilus conjunctivitis, Moraxella conjunctivitis, Acinetobacter calcoaceticus (Herellea vaginacola), and Neisseria. Gentomycin-resistant strains may still be sensitive to tobramycin, but long-term use may lead to bacterial resistance.